Research Paper Volume 16, Issue 8 pp 7188—7216
Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer
Figure 3. Identification cell cycle-related DEGs. (A) An intersection analysis of the TGCA-BRCA prognostic molecules and cell cycle-related DEGs. (B–D) The survival analysis of TPX2/UBE2C/CCNE2 with the indictor, overall survival (OS), disease specific survival (DSS), progress free interval (PFI), respectively. P <0.05 was considered significant.